Variability patterns in dual antiplatelet therapy following endovascular repair of intracranial aneurysms: Insight into regimen heterogeneity and the need for a consensus.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 16 04 2024
accepted: 20 05 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

This comprehensive review delves into the evolving field of neurointervention for intracranial aneurysms, exploring the critical adjunct of Dual Antiplatelet Therapy (DAPT) to endovascular coiling, stent-assisted coiling (SAC), flow-diversion stents, and flow-disruption (intrasaccular) devices. Despite growing evidence supporting the success of DAPT in reducing thromboembolic events, the lack of consensus on optimal regimens, doses, and duration is evident. Factors contributing to this variability include genetic polymorphisms affecting treatment response and ongoing debates regarding the clinical significance of hemorrhagic complications associated with DAPT. This review analyzes pre- and post-procedural antiplatelet usage across various interventions. The imperative lies in ongoing research to define optimal DAPT durations, ensuring a nuanced approach to the delicate balance between thrombosis and hemorrhage in intracranial aneurysm management.

Identifiants

pubmed: 38888678
doi: 10.1007/s00701-024-06137-4
pii: 10.1007/s00701-024-06137-4
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

271

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Références

Adeeb N et al (2017) Use of platelet function testing before pipeline embolization device placement: A multicenter cohort Study. Stroke 48:1322–1330
pubmed: 28411263 doi: 10.1161/STROKEAHA.116.015308
Aguiar G et al (2022) WEB device for treatment of posterior communicating artery aneurysms. J Neurointerv Surg 14:362–365
pubmed: 33975921 doi: 10.1136/neurintsurg-2021-017405
Almekhlafi MA et al (2020) Antiplatelet therapy for prevention of thromboembolic complications in coiling-only procedures for unruptured brain aneurysms. J Neurointerv Surg 12:298–302
pubmed: 31540948 doi: 10.1136/neurintsurg-2019-015173
Alvitigala BY, Gooneratne LV, Constantine GR, Wijesinghe RANK, Arawwawala LDAM (2020) Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy. Pharmacol Res Perspect 8:e00686
pubmed: 33200888 pmcid: 7670852 doi: 10.1002/prp2.686
Baik M, Jeon J, Heo SJ, Yoo J, Kim J (2024) Duration of dual-antiplatelet therapy after stent-assisted coil for unruptured intracranial aneurysm: A nationwide cohort study. International journal of stroke : official journal of the International Stroke Society 19(3):359–366. https://doi.org/10.1177/17474930231207512
doi: 10.1177/17474930231207512 pubmed: 37791650
Becske T et al (2013) Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 267:858–868
pubmed: 23418004 doi: 10.1148/radiol.13120099
Behme D, Berlis A, Weber W (2015) Woven EndoBridge Intrasaccular Flow Disrupter for the Treatment of Ruptured and Unruptured Wide-Neck Cerebral Aneurysms: Report of 55 Cases. AJNR Am J Neuroradiol 36:1501–1506
pubmed: 25953761 pmcid: 7964697 doi: 10.3174/ajnr.A4323
Caroff J et al (2016) Flow-diverter stents for the treatment of saccular middle cerebral artery bifurcation aneurysms. AJNR Am J Neuroradiol 37:279–284
pubmed: 26405085 pmcid: 7959957 doi: 10.3174/ajnr.A4540
Catapano JS et al (2022) Omeprazole-clopidogrel interaction and neurovascular complications after flow-diverter device placement. J Neurointerv Surg 14:380–383
pubmed: 34083398 doi: 10.1136/neurintsurg-2021-017397
Chalouhi N et al (2013) Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke 44:1348–1353
pubmed: 23512976 doi: 10.1161/STROKEAHA.111.000641
Choi HH et al (2023) Delayed ischemic events with low-dose prasugrel medication for stent-assisted coil embolization in intracranial aneurysm patients. Neurosurg Focus 55:E12
pubmed: 37913538 pmcid: 10624113 doi: 10.3171/2023.7.FOCUS22654
Clajus C, Sychra V, Strasilla C, Klisch J (2013) Stent-assisted coil embolization of intracranial aneurysms using the Solitaire™ AB Neurovascular Remodeling Device: initial and midterm follow-up results. Neuroradiology 55:629–638
pubmed: 23386222 doi: 10.1007/s00234-013-1148-7
Dandapat S et al (2021) Review of current intracranial aneurysm flow diversion technology and clinical use. J Neurointerv Surg 13:54–62
pubmed: 32978269 doi: 10.1136/neurintsurg-2020-015877
Da Ros V et al (2019) Ruptured intracranial aneurysms treated with woven endobridge intrasaccular flow disruptor: A multicenter experience. World Neurosurg 122:e498–e505
pubmed: 30394356 doi: 10.1016/j.wneu.2018.10.088
Delgado Almandoz JE et al (2013) Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device. J Neurointerv Surg 59(3):iii3-10
doi: 10.1136/neurintsurg-2012-010582
Despotis GJ, Levine V, Joiner-Maier D, Joist JH (1997) A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 8(7):419–430. https://doi.org/10.1097/00001721-199710000-00007
doi: 10.1097/00001721-199710000-00007
Döring K et al (2023) Early clinical experience with the new generation Pipeline Vantage flow diverter in the treatment of unruptured saccular aneurysms using short-term dual antiplatelet therapy. Interv Neuroradiol 15910199231205048. https://doi.org/10.1177/15910199231205047
Enomoto Y et al (2023) Optimal duration of dual antiplatelet therapy for stent-assisted coiling or flow diverter placement. J Neurointerv Surg. https://doi.org/10.1136/jnis-2023-020285
doi: 10.1136/jnis-2023-020285 pmcid: 11041548
ESC/EACTS Guidelines on myocardial revascularization (2014) Eur Heart J 35:2541–2619
doi: 10.1093/eurheartj/ehu278
Finneran MM, Young M, Farhat H (2020) Antiplatelet therapy for stent-assisted coil of ruptured middle cerebral artery bifurcation aneurysm: Is there a right answer? Cureus 12:e11612
pubmed: 33364129 pmcid: 7752792
Fiorella D et al (2006) Neuroform in-stent stenosis: incidence, natural history, and treatment strategies. Neurosurgery 59:34–42
pubmed: 16823298
Fontana P, Zufferey A, Daali Y, Reny J-L (2014) Antiplatelet therapy: targeting the TxA2 pathway. J Cardiovasc Transl Res 7:29–38
pubmed: 24353037 doi: 10.1007/s12265-013-9529-1
Gao X, Liang G, Li Z, Wei X, Hong Q (2011) Complications and adverse events associated with Neuroform stent-assisted coiling of wide-neck intracranial aneurysms. Neurol Res 33:841–852
pubmed: 22004708 doi: 10.1179/1743132811Y.0000000012
Geyik S, Yavuz K, Yurttutan N, Saatci I, Cekirge HS (2013) Stent-assisted coiling in endovascular treatment of 500 consecutive cerebral aneurysms with long-term follow-up. AJNR Am J Neuroradiol 34:2157–2162
pubmed: 23886748 pmcid: 7964833 doi: 10.3174/ajnr.A3574
Goh C, Churilov L, Mitchell P, Dowling R, Yan B (2013) Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 34:721–726
pubmed: 23275598 pmcid: 7964475 doi: 10.3174/ajnr.A3418
Gorelick PB, Weisman SM (2005) Risk of Hemorrhagic Stroke With Aspirin Use. Stroke 36:1801–1807
pubmed: 16020759 doi: 10.1161/01.STR.0000174189.81153.85
Guglielmi G, Viñuela F, Dion J, Duckwiler G (1991) Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: Preliminary clinical experience. J Neurosurg 75:8–14
pubmed: 2045924 doi: 10.3171/jns.1991.75.1.0008
Guglielmi G, Viñuela F, Sepetka I, Macellari V (1991) Electrothrombosis of saccular aneurysms via endovascular approach. Part 1: Electrochemical basis, technique, and experimental results. J Neurosurg 75:1–7
pubmed: 2045891 doi: 10.3171/jns.1991.75.1.0001
Gupta R et al (2016) Evaluating imaging follow-up strategies and costs of unruptured intracranial aneurysms treated with endovascular techniques: a survey of academic neurovascular centers in the united states. World Neurosurg 94:360–367
pubmed: 27436215 doi: 10.1016/j.wneu.2016.07.030
Higashiguchi S et al (2021) Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel. J Neurointerv Surg 13:1044–1048
pubmed: 33632886 pmcid: 8526880 doi: 10.1136/neurintsurg-2020-016994
Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Guide to Anticoagulant Therapy: Heparin. Circulation 103:2994–3018
pubmed: 11413093 doi: 10.1161/01.CIR.103.24.2994
Hosoo H et al (2022) Antiplatelet therapy and periprocedural risk factor analysis for pipeline embolization device treatment of unruptured internal carotid artery aneurysms: a retrospective, multicenter analysis. World Neurosurg 157:e102–e110
pubmed: 34610445 doi: 10.1016/j.wneu.2021.09.109
Hwang G et al (2010) Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication. Neurosurgery 67:743–748
pubmed: 20651627 doi: 10.1227/01.NEU.0000374770.09140.FB
Hwang G et al (2015) Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 72:764–772
pubmed: 26010803 doi: 10.1001/jamaneurol.2015.0654
Jakubowski JA et al (2017) The Rationale for and Clinical Pharmacology of Prasugrel 5 mg. Am J Cardiovasc Drugs 17:109–121
pubmed: 27854064 doi: 10.1007/s40256-016-0202-3
Kabbasch C et al (2019) WEB embolization versus stent-assisted coiling: comparison of complication rates and angiographic outcomes. J Neurointerv Surg 11:812–816
pubmed: 30674636 doi: 10.1136/neurintsurg-2018-014555
Kang J et al (2019) Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs. Thromb Haemost 119:149–162
pubmed: 30597509 doi: 10.1055/s-0038-1676545
Kaya HE, Bakdık S, Keskin F, Erdi MF, Koç O (2020) Endovascular treatment of intracranial aneurysms using the Woven EndoBridge (WEB) device: retrospective analysis of a single center experience. Clin Imaging 59:25–29
pubmed: 31715514 doi: 10.1016/j.clinimag.2019.09.001
Kim KS, Fraser JF, Grupke S, Cook AM (2018) Management of antiplatelet therapy in patients undergoing neuroendovascular procedures. J Neurosurg 129:890–905
pubmed: 29192856 doi: 10.3171/2017.5.JNS162307
Koh JS et al (2023) Tailored antiplatelet therapy in stent assisted coiling for unruptured aneurysms: a nationwide registry study. J Neurointerv Surg 15:1095–1104
pubmed: 36596671 doi: 10.1136/jnis-2022-019571
Liebig T et al (2015) Intrasaccular Flow Disruption in Acutely Ruptured Aneurysms: A Multicenter Retrospective Review of the Use of the WEB. AJNR Am J Neuroradiol 36:1721–1727
pubmed: 26138139 pmcid: 7968782 doi: 10.3174/ajnr.A4347
Limdi NA et al (2020) Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. Pharmacogenomics J 20:724–735
pubmed: 32042096 pmcid: 7417282 doi: 10.1038/s41397-020-0162-5
Ma Y et al (2022) Safety and efficacy of dual antiplatelet therapy combining aspirin and ticagrelor in patients with undergoing intracranial stenting procedures. J Neurosurg Sci. https://doi.org/10.23736/S0390-5616.22.05745-9
doi: 10.23736/S0390-5616.22.05745-9 pubmed: 36112120
Ma A et al (2023) Antiplatelet Therapy in Neurointervention. Semin Neurol 43:466–479
pubmed: 37562452 doi: 10.1055/s-0043-1771383
Meyer BM et al (2023) Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms. Biomedicines 11(8):2234
pubmed: 37626730 pmcid: 10452183 doi: 10.3390/biomedicines11082234
Moore JM et al (2017) A multicenter cohort comparison study of the safety, efficacy, and cost of ticagrelor compared to clopidogrel in aneurysm flow diverter procedures. Neurosurgery 81:665–671
pubmed: 28475757 doi: 10.1093/neuros/nyx079
Nagahama Y et al (2018) Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg 129:702–710
pubmed: 29099296 doi: 10.3171/2017.5.JNS17831
Narata AP et al (2019) Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery 84:77–83
pubmed: 29490066 doi: 10.1093/neuros/nyy002
Nishi H et al (2016) Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J Neurointerv Surg 8:949–953
pubmed: 26297788 doi: 10.1136/neurintsurg-2015-011844
Nishikawa Y et al (2013) Efficacy and safety of single versus dual antiplatelet therapy for coiling of unruptured aneurysms. J Stroke Cerebrovasc Dis 22:650–655
pubmed: 22440685 doi: 10.1016/j.jstrokecerebrovasdis.2012.02.008
Oran I, Cinar C, Bozkaya H, Korkmaz M (2015) Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation. J Neurointerv Surg 7:357–362.  https://doi.org/10.1136/neurintsurg-2013-011023
Ozaki T et al (2023) Relation between duration of dual antiplatelet therapy and risk of ischemic stroke after stent-assisted treatment of cerebral aneurysm (DAPTS ACE-registry). J Neurointerv Surg jnis-2023–020495. https://doi.org/10.1136/jnis-2023-020495
Ozpeynirci Y, Braun M, Pala A, Schick M, Schmitz B (2019) WEB-only treatment of ruptured and unruptured intracranial aneurysms: a retrospective analysis of 47 aneurysms. Acta Neurochir (Wien) 161:1507–1513
pubmed: 31240584 doi: 10.1007/s00701-019-03988-0
Papaxanthos J et al (2023) Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter. J Neuroradiol 50:346–351
pubmed: 36642161 doi: 10.1016/j.neurad.2022.11.010
Patrignani P, Filabozzi P, Patrono C (1982) Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 69:1366–1372
pubmed: 7045161 pmcid: 370209 doi: 10.1172/JCI110576
Pearce S et al (2021) Antiplatelet Drugs for Neurointerventions: Part 2 Clinical Applications. Clin Neuroradiol 31:545–558
pubmed: 33646319 doi: 10.1007/s00062-021-00997-4
Pierot L (2011) Flow diverter stents in the treatment of intracranial aneurysms: Where are we? J Neuroradiol 38:40–46
pubmed: 21257202 doi: 10.1016/j.neurad.2010.12.002
Pierot L et al (2023) Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up. J Neurointerv Surg 15:552–557
pubmed: 35803731 doi: 10.1136/neurintsurg-2021-018414
Pierot L, Gawlitza M, Soize S (2017) Unruptured intracranial aneurysms: management strategy and current endovascular treatment options. Expert Rev Neurother 17:977–986
pubmed: 28832231 doi: 10.1080/14737175.2017.1371593
Pierot L, Spelle L, Molyneux A, Byrne J; Webcast and French Observatory Investigators (2016) Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With the WEB Device: 1-Year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST and French Observatory). Neurosurgery 78:133–41
Podlasek A et al (2020) Outcome of intracranial flow diversion according to the antiplatelet regimen used: a systematic review and meta-analysis. J Neurointerv Surg 12:148–155
pubmed: 31273075 doi: 10.1136/neurintsurg-2019-014996
Popielski J, Berlis A, Weber W, Fischer S (2018) Two-center experience in the endovascular treatment of ruptured and unruptured intracranial aneurysms using the web device: a retrospective analysis. AJNR Am J Neuroradiol 39:111–117
pubmed: 29051205 pmcid: 7410711 doi: 10.3174/ajnr.A5413
QoorchiMohebSeraj F et al (2023) Safety of dual antiplatelet therapy in the acute phase of aneurysmal subarachnoid hemorrhage: a propensity score-matched study. Neurosurg Focus 55:E10
doi: 10.3171/2023.7.FOCUS23376
Ries T et al (2006) Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 37:1816–1821
pubmed: 16778126 doi: 10.1161/01.STR.0000226933.44962.a6
Russo R et al (2021) Neuroform Atlas stent-assisted coiling of ruptured intracranial aneurysms: A multicenter study. J Neuroradiol 48:479–485
pubmed: 32205256 doi: 10.1016/j.neurad.2020.02.006
Saber H et al (2019) Antiplatelet therapy and the risk of ischemic and hemorrhagic complications associated with Pipeline embolization of cerebral aneurysms: a systematic review and pooled analysis. J Neurointerv Surg 11:362–366
pubmed: 30201813 doi: 10.1136/neurintsurg-2018-014082
Scharf RE (2012) Drugs that affect platelet function. Semin Thromb Hemost 38:865–883
pubmed: 23111864 doi: 10.1055/s-0032-1328881
Schirmer CM et al (2023) Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update. J Neurointerv Surg 15:1155–1162
pubmed: 37188504 doi: 10.1136/jnis-2022-019844
Schrör K (1998) Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel. Vasc Med 3:247–251
pubmed: 9892518 doi: 10.1177/1358836X9800300312
Shapiro M, Becske T, Sahlein D, Babb J, Nelson PK (2012) Stent-supported aneurysm coiling: a literature survey of treatment and follow-up. AJNR Am J Neuroradiol 33:159–163
pubmed: 22033717 pmcid: 7966171 doi: 10.3174/ajnr.A2719
Shimamura N et al (2020) Use of preprocedural, multiple antiplatelet medications for coil embolization of ruptured cerebral aneurysm in the acute stage improved clinical outcome and reduced thromboembolic complications without hemorrhagic complications. World Neurosurg 133:e751–e756
pubmed: 31604135 doi: 10.1016/j.wneu.2019.09.149
Sibbing D et al (2019) Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. JACC Cardiovasc Interv 12:1521–1537
pubmed: 31202949 doi: 10.1016/j.jcin.2019.03.034
Suyama K et al (2023) Efficacy and Safety of Dual Antiplatelet Therapy with the Routine Use of Prasugrel for Flow Diversion of Cerebral Unruptured Aneurysms. Clin Neuroradiol. https://doi.org/10.1007/s00062-023-01355-2
doi: 10.1007/s00062-023-01355-2 pubmed: 37847296 pmcid: 10881594
Tähtinen OI et al (2009) Wide-necked intracranial aneurysms: treatment with stent-assisted coil embolization during acute (<72 hours) subarachnoid hemorrhage–experience in 61 consecutive patients. Radiology 253:199–208
pubmed: 19710006 doi: 10.1148/radiol.2531081923
Takase H et al (2022) Antiplatelet therapy for standalone coiling of ruptured intracranial aneurysms: a systematic review and meta-analysis. J Neurointerv Surg 14:1207–1212
pubmed: 35101959 doi: 10.1136/neurintsurg-2021-018346
Tarlov N, Norbash AM, Nguyen TN (2013) The safety of anticoagulation in patients with intracranial aneurysms. J Neurointerv Surg 5:405–409
pubmed: 22679130 doi: 10.1136/neurintsurg-2012-010359
Texakalidis P et al (2017) Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review. Clin Neurol Neurosurg 161:78–87
pubmed: 28863286 doi: 10.1016/j.clineuro.2017.08.003
Tonetti DA, Jankowitz BT, Gross BA (2020) Antiplatelet Therapy in Flow Diversion. Neurosurgery 86:S47–S52
pubmed: 31838537 doi: 10.1093/neuros/nyz391
van Rooij SBT et al (2017) WEB treatment of ruptured intracranial aneurysms: A single-center cohort of 100 patients. AJNR Am J Neuroradiol 38:2282–2287
pubmed: 28882858 pmcid: 7963751 doi: 10.3174/ajnr.A5371
van Rooij S et al (2020) A systematic review and meta-analysis of Woven EndoBridge single layer for treatment of intracranial aneurysms. Interv Neuroradiol 26:455–460
pubmed: 32028824 pmcid: 7446584 doi: 10.1177/1591019920904421
van Rooij SB, van Rooij WJ, Peluso JP, Sluzewski M (2018) The Woven EndoBridge (WEB) as primary treatment for unruptured intracranial aneurysms. Interv Neuroradiol 24:475–481
pubmed: 29768963 pmcid: 6116134 doi: 10.1177/1591019918772174
Wang X, Luo L, Wang Y, An Z (2023) Effect of platelet function testing guidance on clinical outcomes for patients with intracranial aneurysms undergoing endovascular treatment. AJNR Am J Neuroradiol 44:928–933
pubmed: 37414457 doi: 10.3174/ajnr.A7923
Wilson TJ et al (2014) Dual antiplatelet therapy plus postoperative heparin and dextran is safe and effective for reducing risk of embolic stroke during aneurysm coiling. Acta Neurochir 156:855–859
pubmed: 24595538 doi: 10.1007/s00701-014-2031-y
Xie Y, Tian H, Xiang B, Liu J, Xiang H (2022) Woven EndoBridge device for the treatment of ruptured intracranial aneurysms: A systematic review of clinical and angiographic results. Interv Neuroradiol 28:240–249
pubmed: 34159820 doi: 10.1177/15910199211026712
Yamada NK et al (2007) Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 28:1778–1782
pubmed: 17885244 pmcid: 8134203 doi: 10.3174/ajnr.A0641
Young CC et al (2022) Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy. J Clin Neurosci 105:66–72
pubmed: 36113244 doi: 10.1016/j.jocn.2022.09.005
Zakeri AS, Nimjee SM (2018) Use of Antiplatelet Agents in the Neurosurgical Patient. Neurosurg Clin N Am 29:517–527
pubmed: 30223964 doi: 10.1016/j.nec.2018.06.004
Zhang X-D et al (2011) Delayed intracranial hemorrhage associated with antiplatelet therapy in stent-assisted coil embolized cerebral aneurysms. Acta Neurochir Suppl 110:133–139
pubmed: 21125459

Auteurs

Aryan Wadhwa (A)

Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St, Boston, MA, 02215, USA.

Emmanuel Mensah (E)

Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St, Boston, MA, 02215, USA.

Michael Young (M)

Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St, Boston, MA, 02215, USA.

Christopher S Ogilvy (CS)

Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St, Boston, MA, 02215, USA. cogilvy@bidmc.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH